Description

Onglyza (Saxagliptin) Coated Tablets 5 mg. №30

Ingredients:

• Each tablet contains 5 mg of saxagliptin.

Dosage:

• The recommended dose is one 5 mg tablet once daily.

Indications:

• Onglyza is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Contraindications:

• Do not use Onglyza in patients with a history of a serious hypersensitivity reaction to saxagliptin.

Directions:

• Take Onglyza by mouth with or without food as directed by your doctor, usually once daily.

Scientific Evidence:

Onglyza (saxagliptin) is a dipeptidyl peptidase-4 (DPP-4) inhibitor that works by increasing the levels of incretin hormones in the body, which helps to lower blood sugar levels in patients with type 2 diabetes. Clinical studies have shown that saxagliptin, as monotherapy or in combination with other antidiabetic agents, significantly reduces hemoglobin A1c levels and improves glycemic control.

Additional Information:

• Onglyza has been well-tolerated in clinical trials with a low risk of hypoglycemia. It is important to follow the prescribed dosage and monitor blood sugar levels regularly while taking this medication.
• Research published in the American Journal of Medicine has demonstrated the cardiovascular safety of saxagliptin, providing further support for its use in patients with diabetes at risk for cardiovascular events.